128 related articles for article (PubMed ID: 23966630)
1. Guanine modification of inhibitory oligonucleotides potentiates their suppressive function.
Römmler F; Jurk M; Uhlmann E; Hammel M; Waldhuber A; Pfeiffer L; Wagner H; Vollmer J; Miethke T
J Immunol; 2013 Sep; 191(6):3240-53. PubMed ID: 23966630
[TBL] [Abstract][Full Text] [Related]
2. Guanine-modified inhibitory oligonucleotides efficiently impair TLR7- and TLR9-mediated immune responses of human immune cells.
Römmler F; Hammel M; Waldhuber A; Müller T; Jurk M; Uhlmann E; Wagner H; Vollmer J; Miethke T
PLoS One; 2015; 10(2):e0116703. PubMed ID: 25695778
[TBL] [Abstract][Full Text] [Related]
3. DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo.
Lenert P; Yasuda K; Busconi L; Nelson P; Fleenor C; Ratnabalasuriar RS; Nagy PL; Ashman RF; Rifkin IR; Marshak-Rothstein A
Arthritis Res Ther; 2009; 11(3):R79. PubMed ID: 19476613
[TBL] [Abstract][Full Text] [Related]
4. Aggregation and secondary loop structure of oligonucleotides do not determine their ability to inhibit TLR9.
Ashman RF; Goeken JA; Lenert PS
Int Immunopharmacol; 2011 Aug; 11(8):1032-7. PubMed ID: 21376154
[TBL] [Abstract][Full Text] [Related]
5. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
Anders HJ; Vielhauer V; Eis V; Linde Y; Kretzler M; Perez de Lema G; Strutz F; Bauer S; Rutz M; Wagner H; Gröne HJ; Schlöndorff D
FASEB J; 2004 Mar; 18(3):534-6. PubMed ID: 14734643
[TBL] [Abstract][Full Text] [Related]
6. DNA Nanoflowers' Amelioration of Lupus Symptoms in Mice via Blockade of TLR7/9's Signal.
Wang J; Gan M
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555668
[TBL] [Abstract][Full Text] [Related]
7. Agonists of Toll-like receptor 9 containing synthetic dinucleotide motifs.
Yu D; Putta MR; Bhagat L; Li Y; Zhu F; Wang D; Tang JX; Kandimalla ER; Agrawal S
J Med Chem; 2007 Dec; 50(25):6411-8. PubMed ID: 17988082
[TBL] [Abstract][Full Text] [Related]
8. Engagement of the B cell receptor for antigen differentially affects B cell responses to Toll-like receptor-7 agonists and antagonists in BXSB mice.
Layer T; Steele A; Goeken JA; Fleenor S; Lenert P
Clin Exp Immunol; 2011 Mar; 163(3):392-403. PubMed ID: 21235537
[TBL] [Abstract][Full Text] [Related]
9. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
Vollmer J; Weeratna RD; Jurk M; Samulowitz U; McCluskie MJ; Payette P; Davis HL; Schetter C; Krieg AM
Immunology; 2004 Oct; 113(2):212-23. PubMed ID: 15379982
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship of a guanine-free oligodeoxynucleotide as immunopotent inhibitor.
Zhang YS; Wu XL; Wang Y; Sun R; Yu YL; Wang LY
Int Immunopharmacol; 2012 Aug; 13(4):446-53. PubMed ID: 22664144
[TBL] [Abstract][Full Text] [Related]
11. Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs.
Hackl D; Loschko J; Sparwasser T; Reindl W; Krug AB
Eur J Immunol; 2011 May; 41(5):1334-43. PubMed ID: 21469103
[TBL] [Abstract][Full Text] [Related]
12. Optimal oligonucleotide sequences for TLR9 inhibitory activity in human cells: lack of correlation with TLR9 binding.
Ashman RF; Goeken JA; Latz E; Lenert P
Int Immunol; 2011 Mar; 23(3):203-14. PubMed ID: 21393636
[TBL] [Abstract][Full Text] [Related]
13. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ
J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251
[TBL] [Abstract][Full Text] [Related]
14. Oligodeoxyribonucleotide-based antagonists for Toll-like receptors 7 and 9.
Wang D; Bhagat L; Yu D; Zhu FG; Tang JX; Kandimalla ER; Agrawal S
J Med Chem; 2009 Jan; 52(2):551-8. PubMed ID: 19102653
[TBL] [Abstract][Full Text] [Related]
15. Self-assembling DNA hydrogel-based delivery of immunoinhibitory nucleic acids to immune cells.
Nishida Y; Ohtsuki S; Araie Y; Umeki Y; Endo M; Emura T; Hidaka K; Sugiyama H; Takahashi Y; Takakura Y; Nishikawa M
Nanomedicine; 2016 Jan; 12(1):123-30. PubMed ID: 26364795
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
Kandimalla ER; Bhagat L; Li Y; Yu D; Wang D; Cong YP; Song SS; Tang JX; Sullivan T; Agrawal S
Proc Natl Acad Sci U S A; 2005 May; 102(19):6925-30. PubMed ID: 15860583
[TBL] [Abstract][Full Text] [Related]
17. Suppression of B-cell activation and IgE, IgA, IgG1 and IgG4 production by mammalian telomeric oligonucleotides.
Sackesen C; van de Veen W; Akdis M; Soyer O; Zumkehr J; Ruckert B; Stanic B; Kalaycı O; Alkan SS; Gursel I; Akdis CA
Allergy; 2013; 68(5):593-603. PubMed ID: 23480796
[TBL] [Abstract][Full Text] [Related]
18. CpG-C ISS-ODN activation of blood-derived B cells from healthy and chronic immunodeficiency virus-infected macaques.
Teleshova N; Kenney J; Williams V; Van Nest G; Marshall J; Lifson JD; Sivin I; Dufour J; Bohm R; Gettie A; Pope M
J Leukoc Biol; 2006 Feb; 79(2):257-67. PubMed ID: 16443827
[TBL] [Abstract][Full Text] [Related]
19. Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus.
Lenert PS
Arthritis Res Ther; 2006; 8(1):203. PubMed ID: 16542467
[TBL] [Abstract][Full Text] [Related]
20. Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release.
Hong Z; Jiang Z; Liangxi W; Guofu D; Ping L; Yongling L; Wendong P; Minghai W
Int Immunopharmacol; 2004 Feb; 4(2):223-34. PubMed ID: 14996414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
